Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia
Sponsor: Medtronic Cardiac Ablation Solutions
A NA clinical study on Ventricular Tachycardia (VT), this trial is actively recruiting participants. The trial is conducted by Medtronic Cardiac Ablation Solutions and has accumulated 10 data snapshots since 2025. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
10 versions recorded-
Mar 2026 — Present [monthly]
Recruiting NA
-
Feb 2026 — Mar 2026 [monthly]
Recruiting NA
-
Jan 2026 — Feb 2026 [monthly]
Recruiting NA
-
Nov 2025 — Jan 2026 [monthly]
Recruiting NA
-
Oct 2025 — Nov 2025 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
▶ Show 5 earlier versions
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2025 — Sep 2025 [monthly]
Recruiting NA
-
May 2025 — Jun 2025 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2025 — May 2025 [monthly]
Not Yet Recruiting NA
-
Dec 2024 — Mar 2025 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Cardiac Ablation Solutions
For direct contact, visit the study record on ClinicalTrials.gov .